Volume : 09, Issue : 03, March – 2022
Title:
33.ROLE OF MONITORING HAEMOGLOBIN A1C IN DIABETIC PATIENT-REVIEW
Authors :
Odai Mohammed Albahli, Salah Gazi Alotabi
Abstract :
Many guidelines recommends measuring hemoglobin A1C levels (A1C) at least semiannually in diabetic patients who have stable glycemic control and quarterly in patients whose therapy has changed or who are not meeting glycemic goals. A comprehensive search using electronic databases; MEDLINE, EMBASE, and google scholar, through 2021. Search strategies used following MeSH terms in searching via these databases: “HBA1c” “diabetic patients”, “diagnostic”, “diabetes”. The prognostic potential of HbA1c depends on its special ability of evaluating retrospective glycemic control as well as forecasting the lipid account in diabetic person clients. As the epidemic of diabetic issues remains to grow worldwide, HbA1c examination might continue to be applied as component of the analysis as well as prognostic tool, bring about much better client care and effective professional results.
Cite This Article:
Please cite this article in press Odai Mohammed Albahli et al, Role Of Monitoring Haemoglobin A1c In Diabetic Patient-Review., Indo Am. J. P. Sci, 2022; 09(3),.
Number of Downloads : 10
References:
1. Khan MI, Weinstock RS. Chapter 16: Carbohydrates. In: McPherson RA, Pincus MR, editors. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. Philadelphia, PA: Saunders Elsevier; 2011. pp. 210–25.
2. World Health Organization (WHO) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation. Geneva: WHO; 2011.
3. Huisman TH, Martis EA, Dozy A. Chromatography of hemoglobin types on carboxymethylcellulose. J Lab Clin Med. 1958;52:312–27.
4. Bookchin RM, Gallop PM. Structure of haemoglobin A1c: nature of the N-terminal beta chain blocking group. Biochem Biophys Res Commun. 1968;32:86–93.
5. Little RR, Rohlfing CL. The long and winding road to optimal HbA1c measurement. Clin Chim Acta 2013; 418:63–71.
6. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 1976; 295:417–420.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–986.
8. Nathan DM, Cleary PA, Backlund JY, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643–2653.
9. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32:1327–1334.
10. Ohtsubo K, Chen MZ, Olefsky JM, Marth JD. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med. 2011;17:1067–75.
11. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95-104. Published 2016 Jul 3. doi:10.4137/BMI.S38440
12. Acharya AS, Roy RP, Dorai B. Aldimine to ketoamine isomerization (Amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin A: preferential inhibition of glycation by nucleophiles at sites of low isomerization potential. J Protein Chem. 1991;10:345–58.
13. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. World Health Organization website. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf.
14. Mahfouz AA, Abdelmoneim I, Khan MY, et al. Obesity and related behaviors among adolescent school boys in Abha city, southwestern Saudi Arabia. J Trop Pediatr. 2007;54:120–4.
15. American Diabetes Association. Classification and diagnosis of diabetes. Sec 2. In: Standards of Medical Care in Diabetes—2015. Diabetes Care 2015; 38(suppl 1):S8–S16.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183–1197.
17. Zhang X, Gregg EW, Williamson DF, et al. A1c level and future risk of diabetes: a systematic review. Diabetes Care 2010; 33:1665–1673.
18. Forbes JM, Soldatos G, Thomas MC. Below the radar: advanced glycation end products that detour “around the side”: is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? Clin Biochem Rev. 2005;26:123–34.
19. Luk AO, Ma RC, Lau ES, et al. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev. 2013;29:384–90.
20. Xu R, Zhang S, Tao A, Chen G, Zhang M. Influence of vitamin E supplementation on glycaemic control: a meta-analysis of randomised controlled trials. PLoS One. 2014;9:e95008.
21. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:150–9.
22. Khan HA. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta Diabetol. 2007;44:193–200.
23. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:77–82.
24. Capula C, Mazza T, Vero R, Costante G. HbA1c levels in patients with gestational diabetes mellitus: relationship with pre-pregnancy BMI and pregnancy outcome. J Endocrinol Invest. 2013;36:1038–45.
25. Rizzo G, Pietropolli A, Capponi A, Cacciatore C, Arduini D, Romanini C. Analysis of factors influencing ventricular filling patterns in fetuses of type I diabetic mothers. J Perinat Med. 1994;22:149–57.
26. Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5:444–70.
27. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–11.
28. Lu ZH, Liu N, Bai R, et al. HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation. Herz. 2015;40:130–
29. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) BMJ. 2001;322:15–8.
30. Cicek G, Uyarel H, Ergelen M, et al. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011;22:131–7.
31. Tian L, Zhu J, Liu L, Liang Y, Li J, Yang Y. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study. Coron Artery Dis. 2013;24:16–22.
32. Rebnord EW, Pedersen ER, Strand E, et al. Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study. Atherosclerosis. 2015;240:115–20.
33. Wang X, Han Z, Hao G, Li Y, Dong X, Wang C. Hemoglobin A1c level is not related to the severity of atherosclerosis in patients with acute coronary syndrome. Dis Markers. 2015;2015:1–5.
34. Kompoti M, Michalia M, Salma V, Diogou E, Lakoumenta A, Clouva-Molyvdas PM. Glycated hemoglobin at admission in the intensive care unit: clinical implications and prognostic relevance. J Crit Care. 2015;30:150–5.
35. Pimentel AL, Carvalho LS, Marques SS, et al. Role of glycated hemoglobin in the screening and diagnosis of post-transplantation diabetes mellitus after renal transplantation: a diagnostic accuracy study. Clin Chim Acta. 2015;445:48–53.
36. Helminen O, Aspholm S, Pokka T, et al. HbA1c predicts time to diagnosis of type 1 diabetes in children at risk. Diabetes. 2015;64:1719–27.
37. Consensus Committee Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007;30:2399–400.
38. Forbes JM, Soldatos G, Thomas MC. Below the radar: advanced glycation end products that detour “around the side”: is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? Clin Biochem Rev. 2005;26:123–34.